Eterna Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
1.070
+0.030 (2.88%)
At close: Nov 4, 2024, 4:00 PM
1.120
+0.050 (4.66%)
After-hours: Nov 4, 2024, 4:02 PM EST
Eterna Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 0.16 | 0.07 | - | - | - | - | |
| Cost of Revenue | 0.34 | 0.24 | - | - | - | - | |
| Gross Profit | -0.18 | -0.17 | - | - | - | - | |
| Selling, General & Admin | 16.62 | 14.59 | 16.84 | 14.72 | 3.3 | 3.72 | |
| Research & Development | 5.19 | 5.92 | 10.39 | 12.71 | 3.95 | 5.16 | |
| Operating Expenses | 21.81 | 20.51 | 27.23 | 27.43 | 7.25 | 8.88 | |
| Operating Income | -21.99 | -20.68 | -27.23 | -27.43 | -7.25 | -8.88 | |
| Interest Expense | -2.31 | -0.61 | -0.03 | -0.07 | -0.04 | -0.06 | |
| Interest & Investment Income | 0.23 | 0.14 | - | - | - | - | |
| Other Non Operating Income (Expenses) | 0.08 | -0.12 | 9.89 | -0 | - | - | |
| EBT Excluding Unusual Items | -23.99 | -21.27 | -17.36 | -27.5 | -7.29 | -8.94 | |
| Merger & Restructuring Charges | - | - | - | -5.77 | - | - | |
| Gain (Loss) on Sale of Investments | - | -0.06 | -0.94 | - | - | - | |
| Gain (Loss) on Sale of Assets | - | - | - | -9.65 | - | - | |
| Other Unusual Items | 0.07 | 0.12 | -0.24 | 0.97 | - | - | |
| Pretax Income | -23.93 | -21.67 | -24.53 | -122.48 | -7.29 | -8.94 | |
| Income Tax Expense | -0.01 | -0 | 0.05 | 0.06 | - | - | |
| Net Income | -23.92 | -21.67 | -24.58 | -122.55 | -7.29 | -8.94 | |
| Preferred Dividends & Other Adjustments | 0.02 | 0.02 | 0.02 | 0.02 | - | - | |
| Net Income to Common | -23.94 | -21.68 | -24.6 | -122.56 | -7.29 | -8.94 | |
| Shares Outstanding (Basic) | 5 | 5 | 3 | 2 | 1 | - | |
| Shares Outstanding (Diluted) | 5 | 5 | 3 | 2 | 1 | - | |
| Shares Change (YoY) | 27.24% | 74.17% | 40.92% | 146.19% | - | - | |
| EPS (Basic) | -4.42 | -4.08 | -8.06 | -56.61 | -8.29 | - | |
| EPS (Diluted) | -4.43 | -4.08 | -8.06 | -56.61 | -8.29 | - | |
| Free Cash Flow | -16.86 | -20.43 | -21.27 | -23.64 | -8.14 | -10.41 | |
| Free Cash Flow Per Share | -3.12 | -3.84 | -6.97 | -10.92 | -9.26 | - | |
| Gross Margin | -111.11% | -247.06% | - | - | - | - | |
| Operating Margin | -13572.84% | -30404.41% | - | - | - | - | |
| Profit Margin | -14775.31% | -31888.24% | - | - | - | - | |
| Free Cash Flow Margin | -10408.64% | -30039.71% | - | - | - | - | |
| EBITDA | -21.86 | -20.59 | -27.07 | -27.31 | -7.15 | -8.86 | |
| D&A For EBITDA | 0.13 | 0.08 | 0.16 | 0.12 | 0.1 | 0.02 | |
| EBIT | -21.99 | -20.68 | -27.23 | -27.43 | -7.25 | -8.88 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.